Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
Biomedicines
|
December 23, 2022
Molecular-Targeted Therapy for Tumor-Agnostic Mutations in Acute Myeloid Leukemia
Hironori Arai, Yosuke Minami, SungGi Chi, et al.
Ejhaem
|
April 15, 2026
Reciprocal Clonal Dynamics of Independent <i>FLT3</i> D835V-Positive Acute Myeloid Leukemia and Chronic Myeloid Leukemia With Gilteritinib
Kai Osone, Seiichiro Katagiri, SungGi Chi, et al.
International Journal of Hematology
|
March 31, 2026
Clinical significance of TP53 mutations in patients with acute myeloid leukemia: the HM-SCREEN-JAPAN 01/02 study
Fumiya Ogasawara, Yosuke Minami, SungGi Chi, et al.
International Journal of Molecular Sciences
|
January 11, 2024
Germline Variants and Characteristic Features of Hereditary Hematological Malignancy Syndrome
Hironori Arai, Hirotaka Matsui, SungGi Chi, et al.
Therapeutic Advances in Hematology
|
April 17, 2024
Advancements in minimal residual disease detection: a practical approach using single-cell droplet PCR for comprehensive monitoring in hematological malignancy
Satoshi Uchiyama, Kentaro Fukushima, Seiichiro Katagiri, et al.
Acta Haematologica
|
May 14, 2015
Epstein-Barr Virus-Positive Pyothorax-Associated Lymphoma Arising from a Posttraumatic Empyema
Ayuko Taniguchi, Yumiko Hashida, Yuiko Nemoto, et al.
Oncotargets and Therapy
|
July 19, 2023
Gilteritinib Affects the Selection of Dominant Clones in Clonal Hematopoiesis: Sequential Genetic Analysis of an <i>FLT3</i>-ITD Positive AML Patient with Long-Term Gilteritinib Therapy
Seiichiro Katagiri, Nahoko Furuya, Daigo Akahane, et al.
International Journal of Molecular Sciences
|
June 10, 2022
Molecular Classification and Overcoming Therapy Resistance for Acute Myeloid Leukemia with Adverse Genetic Factors
Daisuke Ikeda, SungGi Chi, Satoshi Uchiyama, et al.
Cureus
|
April 22, 2026
Cardiovascular Events and Management Strategies Including Tyrosine Kinase Inhibitor Switching, Dose Reduction, and Discontinuation in Chronic Myeloid Leukemia: A Single-Center Retrospective Study
Nobue Sato, Ryo Yoshimaru, Yong-Mei Guo, et al.
European Journal of Haematology
|
August 20, 2013
Effect of recombinant human soluble thrombomodulin on clinical outcomes of patients with coagulopathy after hematopoietic stem cell transplantation
Takayuki Ikezoe, Asako Takeuchi, SungGi Chi, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
Biomedicines
|
December 23, 2022
Molecular-Targeted Therapy for Tumor-Agnostic Mutations in Acute Myeloid Leukemia
Hironori Arai, Yosuke Minami, SungGi Chi, et al.
Ejhaem
|
April 15, 2026
Reciprocal Clonal Dynamics of Independent <i>FLT3</i> D835V-Positive Acute Myeloid Leukemia and Chronic Myeloid Leukemia With Gilteritinib
Kai Osone, Seiichiro Katagiri, SungGi Chi, et al.
International Journal of Hematology
|
March 31, 2026
Clinical significance of TP53 mutations in patients with acute myeloid leukemia: the HM-SCREEN-JAPAN 01/02 study
Fumiya Ogasawara, Yosuke Minami, SungGi Chi, et al.
International Journal of Molecular Sciences
|
January 11, 2024
Germline Variants and Characteristic Features of Hereditary Hematological Malignancy Syndrome
Hironori Arai, Hirotaka Matsui, SungGi Chi, et al.
Therapeutic Advances in Hematology
|
April 17, 2024
Advancements in minimal residual disease detection: a practical approach using single-cell droplet PCR for comprehensive monitoring in hematological malignancy
Satoshi Uchiyama, Kentaro Fukushima, Seiichiro Katagiri, et al.
Acta Haematologica
|
May 14, 2015
Epstein-Barr Virus-Positive Pyothorax-Associated Lymphoma Arising from a Posttraumatic Empyema
Ayuko Taniguchi, Yumiko Hashida, Yuiko Nemoto, et al.
Oncotargets and Therapy
|
July 19, 2023
Gilteritinib Affects the Selection of Dominant Clones in Clonal Hematopoiesis: Sequential Genetic Analysis of an <i>FLT3</i>-ITD Positive AML Patient with Long-Term Gilteritinib Therapy
Seiichiro Katagiri, Nahoko Furuya, Daigo Akahane, et al.
International Journal of Molecular Sciences
|
June 10, 2022
Molecular Classification and Overcoming Therapy Resistance for Acute Myeloid Leukemia with Adverse Genetic Factors
Daisuke Ikeda, SungGi Chi, Satoshi Uchiyama, et al.
Cureus
|
April 22, 2026
Cardiovascular Events and Management Strategies Including Tyrosine Kinase Inhibitor Switching, Dose Reduction, and Discontinuation in Chronic Myeloid Leukemia: A Single-Center Retrospective Study
Nobue Sato, Ryo Yoshimaru, Yong-Mei Guo, et al.
European Journal of Haematology
|
August 20, 2013
Effect of recombinant human soluble thrombomodulin on clinical outcomes of patients with coagulopathy after hematopoietic stem cell transplantation
Takayuki Ikezoe, Asako Takeuchi, SungGi Chi, et al.
Page
of 4